This setting is not a flaw, Animas says, because of the house-room analogy: if Dexcom and Animas are two rooms, and you step outside the house and lock the front door, you lose access to both rooms until you go back inside. Luckily, I had my pre-existing G4 receiver by my side so I could see that I was rebounding, even though I still felt pretty low. After I treated, I looked at the Vibe’s CGM screen and realized I had no clue where my blood sugar was heading or whether I needed further treatment. My trainer dropped this bombshell on me during setup, but I forgot about it until a day or so later when… a low blood sugar dropped me down to 54 mg/dL, and I needed to cut off insulin for a bit. No, it doesn’t actually restart the sensor, but it means you can’t see current CGM data until you un-suspend. Here are my observations from my two weeks of trial-testing:ĭual-Suspension: When you suspend your insulin delivery, the CGM data stream is also put on pause. I wasn’t impressed then, but definitely wondered if this slightly-modified version complete with built-in CGM might be enough to turn me into an Animas pumper - but that wasn’t the case.
Keep in mind: I’m coming at this from more than a decade of happy Medtronic pumping, and I’ve only tried the Ping for one month to get a feel for it a year or so ago. Sadly, nothing wowed me personally about the Vibe, and even the built-in CGM isn’t enough to convince me it was worth the wait, or convince me to purchase this system for myself. I found that there are good and not-so-good things about the Vibe, and as with everything, opinions will vary. Now anyone using it gets all the benefits of that combined home’s plumbing, heating, air conditioning, and so on. In the words of my awesome Animas educator during my training in late December: You can think of this system in terms of a dwelling - the two components used to be separate housing units, but now they co-exist under the same roof and are more like different rooms within one big home. There’s been a lot of buildup here in the States, before and after Animas filed with regulators in April 2013, so I had high hopes going into this two-week trial. (after Medtronic’s system), and the first to include the popular Dexcom G4, and it’s been a loooong time coming Dexcom and Animas first announced their joint-development agreement back in January 2008, and this integrated system was launched overseas in mid-2011. This is only the second combined insulin pump-CGM product ever made available in the U.S. We appreciate this opportunity for a trial-run of this exciting new device before it officially hits the market in the coming weeks.
Animas z vibe plus#
For two weeks during the holidays, I test-drove the new Animas Vibe combo device (Animas insulin pump plus Dexcom continuous glucose monitor) approved by FDA just over a month ago.
0 kommentar(er)
